Peng W, Shi M, Hu B, Jia J, Li X, Wang N
Mol Cancer. 2025; 24(1):78.
PMID: 40087758
DOI: 10.1186/s12943-024-02222-5.
Yang Y, Razak S, Ismail I, Ma Y, Yunus M
Cancer Cell Int. 2025; 25(1):94.
PMID: 40087755
DOI: 10.1186/s12935-025-03666-5.
Wassaifi S, Kaeffer B, Zarrouk S
Int J Mol Sci. 2025; 26(5).
PMID: 40076710
PMC: 11900927.
DOI: 10.3390/ijms26052083.
Schiavello M, Bosco O, Vizio B, Sciarrillo A, Pensa A, Pivetta E
Int J Mol Sci. 2025; 26(5).
PMID: 40076471
PMC: 11899136.
DOI: 10.3390/ijms26051844.
Lin T, Meegaskumbura M
Animals (Basel). 2025; 15(5).
PMID: 40075907
PMC: 11898199.
DOI: 10.3390/ani15050624.
Exploring the Role of miRNA-101a in the Circulatory System's Adaptive Mechanisms in Hypertensive Disorders of Pregnancy.
Szczerba E, Kozyra-Pydys E, Zajkowska A, Pankiewicz K, Szewczyk G, Maciejewski T
Diagnostics (Basel). 2025; 15(5).
PMID: 40075783
PMC: 11899601.
DOI: 10.3390/diagnostics15050535.
Extracellular Microvesicle MicroRNAs and Imaging Metrics Improve the Detection of Aggressive Prostate Cancer: A Pilot Study.
Avasthi K, Choi J, Glushko T, Manley B, Yu A, Park J
Cancers (Basel). 2025; 17(5).
PMID: 40075682
PMC: 11898942.
DOI: 10.3390/cancers17050835.
Differential miRNA expression and regulatory mechanisms in pigmentation and fiber development of white and brown cotton (Gossypium hirsutum).
Nayak S, Prasad P, Fakhrah S, Pattanaik D, Bag S, Mohanty C
Funct Integr Genomics. 2025; 25(1):61.
PMID: 40074959
DOI: 10.1007/s10142-025-01568-3.
Optimizing sample size for supervised machine learning with bulk transcriptomic sequencing: a learning curve approach.
Qi Y, Wang X, Qin L
Brief Bioinform. 2025; 26(2).
PMID: 40072846
PMC: 11899567.
DOI: 10.1093/bib/bbaf097.
Pulmonary Hypertension: Molecular Mechanisms and Clinical Studies.
Adu-Amankwaah J, You Q, Liu X, Jiang J, Yang D, Liu K
MedComm (2020). 2025; 6(3):e70134.
PMID: 40066229
PMC: 11892029.
DOI: 10.1002/mco2.70134.
Engineered exosomes restore miR-508-5p expression in uterine corpus endometrial carcinoma and reduce tumor progression and metastasis by targeting DLL3.
Li Y, Liu H, Feng J, Tian W, Du J, Zhang L
Front Oncol. 2025; 15:1532564.
PMID: 40066092
PMC: 11891050.
DOI: 10.3389/fonc.2025.1532564.
Circ_0090100 induces AHNAK expression to inhibit trophoblast cell proliferation and invasion and accelerate cell apoptosis by segregating miR-139-5p in preeclampsia.
Shan Z, Zhou L, Ma Y, Huang Y
Hum Cell. 2025; 38(3):67.
PMID: 40063163
DOI: 10.1007/s13577-025-01185-z.
Piezo1-related physiological and pathological processes in glioblastoma.
Fu W, Hou X, Ding L, Wei J, Hou W
Front Cell Dev Biol. 2025; 13:1536320.
PMID: 40061015
PMC: 11885286.
DOI: 10.3389/fcell.2025.1536320.
The role of ESRP1 in solid tumor development through the regulation of CD44 splicing and EMT processes.
Wang L, Zhang M, Zhao K, Yuan X, Zhao H, Liu Y
Front Oncol. 2025; 15:1451130.
PMID: 40046628
PMC: 11881191.
DOI: 10.3389/fonc.2025.1451130.
miR-145-5p Inhibits HER2-Positive Breast Cancer Cells via Targeting ARF6.
Yang L, Dang W, Kong F, Zhang X, Zheng L, Jia L
Int J Gen Med. 2025; 18:1181-1192.
PMID: 40046454
PMC: 11881773.
DOI: 10.2147/IJGM.S510358.
Impact of Genetic Polymorphisms on Treatment Outcomes of Proteasome Inhibitors and Immunomodulatory Drugs in Multiple Myeloma.
Karimi F, Aghaei M, Saki N
Curr Treat Options Oncol. 2025; .
PMID: 40042740
DOI: 10.1007/s11864-025-01295-8.
Integrative Analysis of scRNA-Seq and Bulk RNA-Seq Identifies Plasma Cell Related Genes and Constructs a Prognostic Model for Hepatocellular Carcinoma.
Tang M, Xu Y, Pan M
J Hepatocell Carcinoma. 2025; 12:427-444.
PMID: 40040881
PMC: 11878290.
DOI: 10.2147/JHC.S509749.
HTLV-1 and HTLV-2 infections significantly alter small RNA expression in asymptomatic carriers.
Fernandes L, Folgosi V, Pessoa R, Assone T, Victor J, Casseb J
Front Med (Lausanne). 2025; 12:1547712.
PMID: 40034383
PMC: 11872698.
DOI: 10.3389/fmed.2025.1547712.
gma-miR828a Negatively Regulates Resistance to Tea Leaf Spot Caused by Lasiodiplodia theobromae Through Targeting the CsMYB28-CsRPP13 Module.
Wen Y, Pan T, Shi Y, Xu J, Wang D, Zhou J
Mol Plant Pathol. 2025; 26(3):e70069.
PMID: 40033647
PMC: 11876294.
DOI: 10.1111/mpp.70069.
Wnt/β-catenin signaling pathway: an attractive potential therapeutic target in osteosarcoma.
Ding Y, Chen Q
Front Oncol. 2025; 14:1456959.
PMID: 40028002
PMC: 11867957.
DOI: 10.3389/fonc.2024.1456959.